MedAvail Holdings, Inc.
MDVLNASDAQHealthcare
$1.80
$-1.37(-43.22%)
Market Cap$2905038
P/E Ratio—
52W High$20.9
52W Low$1.31
MedAvail Holdings, Inc. (MDVL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDVL · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 14, 2023EPS Actual
-$3.06
Est. -$0.03 · -10100.0%
Revenue
$0.00B
Est. $0.00B · -49.4%
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 14, 2023
After Market Close
▼ Miss EPS▼ Miss Revenue
MDVL reports quarterly as a NASDAQ-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | Apr 11, 2024 | — | — | — | — | $0.00B | — |
| ◌ Q1 FY2024 | Feb 21, 2024 | — | — | — | — | $0.00B | — |
| ◌ Q4 FY2023 | Dec 29, 2023 | — | — | — | — | $0.00B | — |
| ▼ Q3 FY2023 | Aug 14, 2023 | -$0.03 | -$3.06 | -10100.0% | $0.00B | $0.00B | -49.4% |
| ▼ Q2 FY2023 | May 18, 2023 | -$0.21 | -$8.00 | -3709.5% | $0.00B | — | — |
| ▼ Q1 FY2023 | Mar 23, 2023 | -$0.16 | -$0.38 | -137.5% | $0.01B | — | — |
| ▼ Q4 FY2022 | Nov 10, 2022 | -$0.15 | -$7.50 | -4900.0% | $0.01B | — | — |
| ▼ Q3 FY2022 | Aug 11, 2022 | -$0.26 | -$8.50 | -3169.2% | $0.01B | — | — |
Q2 FY2024
Apr 11, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 21, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 29, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 14, 2023Miss
EPS Actual
-$3.06
EPS Est.
-$0.03
EPS Surpr.
-10100.0%
Revenue
$0.00B
Q2 FY2023
May 18, 2023Miss
EPS Actual
-$8.00
EPS Est.
-$0.21
EPS Surpr.
-3709.5%
Revenue
$0.00B
Q1 FY2023
Mar 23, 2023Miss
EPS Actual
-$0.38
EPS Est.
-$0.16
EPS Surpr.
-137.5%
Revenue
$0.01B
Q4 FY2022
Nov 10, 2022Miss
EPS Actual
-$7.50
EPS Est.
-$0.15
EPS Surpr.
-4900.0%
Revenue
$0.01B
Q3 FY2022
Aug 11, 2022Miss
EPS Actual
-$8.50
EPS Est.
-$0.26
EPS Surpr.
-3169.2%
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 0 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 0 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 0 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 0 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 0 |
| Q2 FY2023 | $-0.03 | $-0.03 | $-0.03 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2023 | Aug 14, 2023 | -10100.0% | $11.91 | $11.99 | +0.67% |
| ▼ Q2 FY2023 | May 18, 2023 | -3709.5% | $11.60 | $11.75 | +1.29% |
| ▼ Q1 FY2023 | Mar 23, 2023 | -137.5% | $14.80 | $14.95 | +1.01% |
| ▼ Q4 FY2022 | Nov 10, 2022 | -4900.0% | $26.75 | $27.50 | +2.80% |
| ▼ Q3 FY2022 | Aug 11, 2022 | -3169.2% | $57.25 | $60.00 | +4.80% |
| ▼ Q2 FY2022 | May 13, 2022 | -11.1% | $115.50 | $104.50 | -9.52% |
| ▼ Q1 FY2022 | Mar 24, 2022 | -11.8% | $54.00 | $59.00 | +9.26% |
| ▼ Q4 FY2021 | Nov 8, 2021 | -6.3% | $133.50 | $131.00 | -1.87% |
Q3 FY2023+0.67%
Report Date
Aug 14, 2023
EPS Beat/Miss
-10100.0%
Price Before
$11.91
Price After
$11.99
Q2 FY2023+1.29%
Report Date
May 18, 2023
EPS Beat/Miss
-3709.5%
Price Before
$11.60
Price After
$11.75
Q1 FY2023+1.01%
Report Date
Mar 23, 2023
EPS Beat/Miss
-137.5%
Price Before
$14.80
Price After
$14.95
Q4 FY2022+2.80%
Report Date
Nov 10, 2022
EPS Beat/Miss
-4900.0%
Price Before
$26.75
Price After
$27.50
Q3 FY2022+4.80%
Report Date
Aug 11, 2022
EPS Beat/Miss
-3169.2%
Price Before
$57.25
Price After
$60.00
Q2 FY2022-9.52%
Report Date
May 13, 2022
EPS Beat/Miss
-11.1%
Price Before
$115.50
Price After
$104.50
Q1 FY2022+9.26%
Report Date
Mar 24, 2022
EPS Beat/Miss
-11.8%
Price Before
$54.00
Price After
$59.00
Q4 FY2021-1.87%
Report Date
Nov 8, 2021
EPS Beat/Miss
-6.3%
Price Before
$133.50
Price After
$131.00
Avg Miss Reaction+1.06%
Beat Rate0 / 8 quarters
Largest Move-9.52% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDVL ends December
MedAvail Holdings, Inc. (MDVL) most recently reported earnings on August 14, 2023 for Q3 FY2023, posting EPS of $-3.06 — missing the analyst consensus of $-0.03 by -10100.0%. The next MDVL earnings date is expected around September 1, 2026.
Each quarter, investors track MDVL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDVL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDVL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDVL earnings · 5 questionsMedAvail Holdings, Inc.'s next earnings report is expected around September 1, 2026. MDVL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDVL historically reports after market close (AMC).
MDVL earnings datewhen is MDVL earningsMDVL next earnings datewhen does MDVL report earningsMDVL earnings calendar
▸ Source: FMP · MedAvail Holdings, Inc. SEC filings · US GAAP · MedAvail Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026